Antibiotic Resistance in Pediatric UTIs Up Globally

Share this content:
Antibiotic Resistance in Pediatric UTIs Up Globally
Antibiotic Resistance in Pediatric UTIs Up Globally

WEDNESDAY, March 16, 2016 (HealthDay News) -- Many children who develop urinary tract infections (UTIs) tied to the Escherichia coli bacteria are now failing to respond to antibiotic treatment, according to research published online March 15 in The BMJ.

The study team reviewed 58 prior investigations conducted in 26 countries that collectively looked at 77,783 E. coli isolates in urine samples.

Across industrialized nations, 53.4 percent of the pediatric UTI cases were found to be resistant to amoxicillin, one of the most often prescribed primary care antibiotics. Nearly a quarter (23.6 percent) of young patients in industrialized nations were resistant to the antibiotic trimethoprim; 8.2 percent were resistant to co-amoxiclav. Among children in developing nations, resistance was even higher. In poorer countries, 79.8 percent of childhood UTI cases were resistant to amoxicillin, and 60.3 percent were resistant to co-amoxiclav. More than a quarter (26.8 percent) were resistant to ciprofloxacin, and 17.0 percent to nitrofurantoin.

Grant Russell, Ph.D., head of the School of Primary Health Care at Monash University in Melbourne, Australia, and author of an accompanying editorial, warns that if current trends persist, it could lead to a serious situation in which relatively cheap and easy-to-administer oral antibiotics will no longer be of practical benefit to young UTI patients. The result would be a greater reliance on much more costly intravenous medications. Preventing such a scenario is a "global responsibility," Russell told HealthDay, with the goal being to rein in the use and abuse of antibiotics.

Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »